Delivery Order SPE2DB20D3103-SPE2DB23FL4H8
Award Date
10/25/22
Potential Completion Date
10/26/22
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,567,155,753 units of Lidocaine 5% Patch 30s, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $3,873.10 and is a Firm Fixed Price Delivery Order, with a final completion date of February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor, Amerisourcebergen Drug Corp, was awarded a Firm Fixed Price Delivery Order valued at $2,093.83 with a completion date of February 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The $8,603.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,504.70 and is a firm fixed price delivery order with a completion date of May 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,804.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 1, 2024. The contract is not associated with any...
This federal contract award is for the delivery of lidocaine 5% patches to the Defense Logistics Agency (DLA). The $3,453.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 26, 2024 and was awarded on April 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patches. The contract, valued at $8,137.72, is a Firm Fixed Price Delivery Order with a completion date of June 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Lidocaine 5% Patch 30's to the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense. The contract, valued at $1,243.20, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of March 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of 4,561,864,810 units of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The $6,304.52 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 18, 2023. The order has an ultimate completion date of August 21, 2023 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999...
This federal contract award is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,384.18 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of November 9, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...